A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation

Trial Identifier: EFC18554
Sponsor: Sanofi
Start Date: March 2026
Primary Completion Date: August 2029
Study Completion Date: August 2033

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
ARGENTINA, Corrientes Corrientes, ARGENTINA, 3400
AUSTRALIA Sydney, AUSTRALIA, 2050
AUSTRALIA, South Australia Adelaide, South Australia, AUSTRALIA, 5000
AUSTRALIA, Victoria Parkville, Victoria, AUSTRALIA, 3050
Belgium Brussels, Belgium
CHILE, Reg Metropolitana de Santiago Santiago, Reg Metropolitana de Santiago, CHILE, 8330034
CHILE, Reg Metropolitana de Santiago Santiago, Reg Metropolitana de Santiago, CHILE, 8320325
CHINA Chengdu, CHINA, 610041
CHINA Jinan, CHINA, 250014
CHINA Nanchang, CHINA, 330006
CHINA Nanning, CHINA, 530007
CHINA Shanghai, CHINA, 200127
CHINA Tianjin, CHINA, 300192
CHINA Wuhan, CHINA, 430030
CHINA Zhengzhou, CHINA, 450052
CHINA Zhengzhou, CHINA, 450061
DENMARK Aarhus, DENMARK, 8200
ISRAEL Ramat Gan, ISRAEL, 5262100
ITALY, Ancona Torette, Ancona, ITALY, 60020
SPAIN, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], SPAIN, 08035
SPAIN, Catalunya [Cataluña] Barcelona, Catalunya [Cataluña], SPAIN, 08036
SPAIN, Catalunya [Cataluña] L'Hospitalet De Llobregat, Catalunya [Cataluña], SPAIN, 08907
SPAIN, Málaga Málaga, SPAIN, 29010
UNITED KINGDOM, England Birmingham, England, UNITED KINGDOM, B15 2TH
UNITED STATES, Massachusetts Boston, Massachusetts, UNITED STATES, 02115
UNITED STATES, New York Bronx, New York, UNITED STATES, 10467